| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/29/2004 | US20040147512 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/29/2004 | US20040147488 Method of modifying the release profile of sustained release compositions |
| 07/29/2004 | US20040147485 Antiinflammatory agents; antiischemic agents; antiarthritic agents; antihistamines; multiple sclerosis; Alzheimer's disease; Huntington's disease; parkinson's disease; antiepileptic agents; headaches |
| 07/29/2004 | US20040147483 For therapy of viral infection |
| 07/29/2004 | US20040147477 Antisense modulation of P70 S6 kinase expression |
| 07/29/2004 | US20040147476 For therapy and prophylaxis of virus infections, other pathogenic infections or cancers |
| 07/29/2004 | US20040147473 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers |
| 07/29/2004 | US20040147472 Antisense modulation of transforming growth factor beta receptor II expression |
| 07/29/2004 | US20040147471 Antisense modulation of TNFR1 expression |
| 07/29/2004 | US20040147466 For gene expression from a bioabsorbable polymeric network structurally and functionally designed to induce gene expression |
| 07/29/2004 | US20040147465 Treatment for wounds |
| 07/29/2004 | US20040147464 For therapy |
| 07/29/2004 | US20040147456 For therapy and prophylaxis of thrombolytic condition |
| 07/29/2004 | US20040147455 Prodrugs of fused GABA analogs, pharmaceutical compositions and uses thereof |
| 07/29/2004 | US20040147453 Multivalent metal salts of boronic acids |
| 07/29/2004 | US20040147452 Non-amphoteric glutathione derivative compositions for tropical application |
| 07/29/2004 | US20040147451 Animals are injected with an injection solution that contains synthetically produced FSH-releasing hormones with known sequences consisting of 10 amino acids (decapeptide) |
| 07/29/2004 | US20040147450 To promote bone growth in mammals |
| 07/29/2004 | US20040147449 For inhibition of vascularization and for cancer therapy |
| 07/29/2004 | US20040147448 Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof |
| 07/29/2004 | US20040147447 For therapy of cancer or autoimmune diseases |
| 07/29/2004 | US20040147446 Administration of growth hormone or analogues thereof, preferably human growth hormone, in a low dose for therapy of patients in need of increasing insulin sensitivity |
| 07/29/2004 | US20040147445 For therapy and prophylaxis of arthritis and other inflammatory and autoimmune diseases |
| 07/29/2004 | US20040147444 Use of a fusion protein comprising a latency associated peptide and a proteolytic cleavage site for providing latency to a pharmaceutically active agent |
| 07/29/2004 | US20040147443 Use of a combination of components with an inhibitory synergistic effect on calcium channels to prevent or treat winkles and fine lines |
| 07/29/2004 | US20040147442 Thrombin-inhibiting peptides |
| 07/29/2004 | US20040147439 Pharmaceutically stable hemostatic compositions |
| 07/29/2004 | US20040147438 For therapy of neuroblastoma |
| 07/29/2004 | US20040147435 Compositions and methods for importing biologically active molecules into cells and for treating inflammation |
| 07/29/2004 | US20040147434 Use of enzyme inhibitors of the dipeptidypeptidase iv (ec3.3.14.5) in addition to the aminopeptidase n (ec 3.4.11.2), individually or in a combination thereof, and pharmaceutical preparations thereof for the prevention and/or therapy of ischaemia-caused acute and chronic neurodegenerative process and illnesses, for example |
| 07/29/2004 | US20040147433 Preparing a dosage of a neuroimmunophilin ligand selected from cyclosporins and functional derivatives, metabolites, variants, and salts thereof which are able to cross the blood-brain barrier; administering that dosage |
| 07/29/2004 | US20040147432 Melanin-concentrating hormone analogs |
| 07/29/2004 | US20040147431 Erythropoietin composition |
| 07/29/2004 | US20040147430 Using compounds stimulating secretion of insulin, glucosidase inhibitors, thiazolidinediones, insulin, agents enhancing sensitivity to insulin, glucagon-like peptide-1 (GLP-1), PPAR alpha / gamma agonists, meglitinide and aP2 inhibitors |
| 07/29/2004 | US20040147009 Tissue type plasminogen activator (t-PA) variants: compositions and methods of use |
| 07/29/2004 | US20040147006 Amino acid sequences comprising nuclear localization signal petides for use as enzyme inhibitors in treatment of viral and nervous system disorders; gene therapy and mimetics |
| 07/29/2004 | US20040147004 Comprises nucleotide sequences coding enzymatic polypeptide for use as tool in identifying modulators for diagnosis, treatment and prevention of cancer and cell proliferative disorders |
| 07/29/2004 | US20040147003 Comprises nucleotide sequences coding kinase for use as tool in identifying modulators for treatment and prevention cell proliferative disorders |
| 07/29/2004 | US20040146989 Nucleotide sequences coding cytokine fusion protein for use in the prevention and treatment of tumor and viral infections |
| 07/29/2004 | US20040146986 Nucleotide sequences coding transcription factor associated with tumor suppressor activity for use in treatment and prevention of cell proliferative disorders |
| 07/29/2004 | US20040146982 hKIS compositions and methods of use |
| 07/29/2004 | US20040146981 DNA encoding human serine protease D-G |
| 07/29/2004 | US20040146979 Growth/differentiation factor of the TGF-beta family |
| 07/29/2004 | US20040146978 Isolated human Ras-like proteins, nucleic acid molecules encoding human Ras-like proteins, and uses thereof |
| 07/29/2004 | US20040146971 Novel p53 inducible protein |
| 07/29/2004 | US20040146970 Proteins associated with cell growth, differentiation, and death |
| 07/29/2004 | US20040146964 Assays, methods and means |
| 07/29/2004 | US20040146962 Isolated human protease proteins, nucleic acid molecules encoding human protese proteins, and uses thereof |
| 07/29/2004 | US20040146953 Assay |
| 07/29/2004 | US20040146951 from pancreas cells; for drug screening compounds that also bind to somatostatin type-5 receptor ("SSTR-5") |
| 07/29/2004 | US20040146930 for diagnosing susceptibility to a pathological condition based on the presence or absence of mutation; drug screening; genetic engineering |
| 07/29/2004 | US20040146929 for drug screening, in vitro or in vivo diagnosis, and gene therapy; antitumor agents; genetic engineering; kits |
| 07/29/2004 | US20040146928 Human neuronal attachment factor-1 |
| 07/29/2004 | US20040146927 Fibroblast growth factor-14 |
| 07/29/2004 | US20040146925 for diagnosis and targeted drug delivery for blood cancer and monitoring protein expression or activity of white blood cells in vitro |
| 07/29/2004 | US20040146924 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/29/2004 | US20040146923 for treatment of tendinitis and tendon or ligament defects and in related tissue repair, wound healing, and augmenting bone morphogenetic protein (bmp) activity |
| 07/29/2004 | US20040146894 Methods of diagnosing and treating stress urinary incontinence |
| 07/29/2004 | US20040146893 Nucleotide sequences coding heterologous polypeptide for use in diagnosis and treatment of nervous system, cell proliferative, inflammatory and autoimmune diseases; wound healing agents |
| 07/29/2004 | US20040146891 Comprises growth factor for diagnosis and treatment of immunological and cell proliferative disorders |
| 07/29/2004 | US20040146888 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/29/2004 | US20040146884 Antifreeze proteins isolated from forage grasses and methods for their use |
| 07/29/2004 | US20040146882 Human acid sensing ion channel 2b (hASIC2b), process for producing the same, and its use |
| 07/29/2004 | US20040146877 Diagnosis and treatment of cancer:I |
| 07/29/2004 | US20040146872 Comprises nucleotide sequences coding delta-2-enoyl-coA isomerase for use in identifying modulators for treatment and diagnosis of inflammatory, cardiovascular, skin, body weight and cancer disorders |
| 07/29/2004 | US20040146859 Nucleotide sequences coding hemorrhagic viral protein for use in detection and treatment of viral diseases; viricides; genetic vaccines |
| 07/29/2004 | US20040146851 Identifying compounds which modulate phosphatidylserine exposure on the surface of megakaryocytes for use in treating thrombosis, bleeding and apoptosis disorders |
| 07/29/2004 | US20040146595 Breast cancer ; therapy containing plant extracts |
| 07/29/2004 | US20040146554 Providing an active pharmaceutical compound; providing a basic salt as one of a powder, a suspension and a solution having a pH greater than 7; combining; delivering the non-enteric coated liquid formulation |
| 07/29/2004 | US20040146552 Lipopeptides that are immunomodulators encapsulated as liposomes or free-form for the treatment of neoplasia and in reducing chemotherapeutically induced cellular pathology, including mucositis |
| 07/29/2004 | US20040146549 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 07/29/2004 | US20040146532 Agents and methods for treating pain |
| 07/29/2004 | US20040146528 MVA expressing modified HIV envelope, gag, and pol genes |
| 07/29/2004 | US20040146526 Inhibition of NF-kappaB activation |
| 07/29/2004 | US20040146525 Shellfish protein |
| 07/29/2004 | US20040146523 Use of the protein UK114, also known as MSP 14, for the preparation of medicaments for the treatment or the prophylaxis of chronic active hepatitis |
| 07/29/2004 | US20040146522 For therapy of individual exposed to or infected with HIV-1 |
| 07/29/2004 | US20040146520 Materials and methods relating to immune suppression |
| 07/29/2004 | US20040146511 Administering an anti-coagulation factor monoclonal antibody having self-limiting neutralizing activity with plasminogen activator |
| 07/29/2004 | US20040146510 Genetically engineered polypeptides as wound healing agents; treatment of nervous system, vision, kidney, and liver disorders; stimulating embryogenesis and angiogenesis; antitumor agents; drug screening, diagnosis |
| 07/29/2004 | US20040146506 Antibodies specific for a cell surface molecule mediating cell adhesion and signal transmission, cells secreting such antibodies, and methods of making and using such antibodies |
| 07/29/2004 | US20040146505 Polypeptide comprising portion with part of human fc fragment which binds to CD64 antigen, and portion comprising heterologous T cell epitopes; antitumor and anticarcinogenic agents |
| 07/29/2004 | US20040146498 3-(2,3-Dihydroxycyclopentyl)-6-alkylthio-8-cyclopropylamino-3H-v-triazolo[4,5-d]pyrimidine derivatives as anticoagulants |
| 07/29/2004 | US20040146497 Wound healing agents and/or angiogenesis promoters; genetic engineering |
| 07/29/2004 | US20040146496 Treatment of Dupuytren's contracture, scleroderma, Peyronie's disease, bovine mastistis and claudication due to peripheral arterial disease |
| 07/29/2004 | US20040146495 Analyzing a blood sample for secretin level |
| 07/29/2004 | US20040146494 Papaine containing pharmaceutical formulation resp its use |
| 07/29/2004 | US20040146488 Gene expression of protein with ability to chaperon antigenic peptides of tumor cells to antigen-presenting cells (APCs); selective replication in and killilng of tumor cells; immunotherapy; antimetastasis and anticarcinogenic agents |
| 07/29/2004 | US20040146486 One unit engineered to constitutively express co-stimulator and another can be engineered to express single, fusion or multiple antigens derived from disease causing pathogen |
| 07/29/2004 | US20040146485 Vaccines including as an adjuvant type 1 ifn and process related thereto |
| 07/29/2004 | US20040146484 Amended recombinant cells for the production and delivery of gamma interferon as an antiviral agent, adjuvant and vaccine accelerant |
| 07/29/2004 | US20040146470 Vitamin E and excipient |
| 07/29/2004 | US20040146459 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 07/29/2004 | DE10302422A1 Composition for treating cancer, particularly carcinoma of the breast, and that reduces tumor mass in only a few days, comprises annexin V and a cytokine, such as an interleukin or granulocyte-macrophage colony-stimulating factor |
| 07/29/2004 | DE10302421A1 New double-stranded interfering RNA, useful for inhibiting hepatitis C virus, has one strand linked to a lipophilic group to improve activity and eliminate the need for transfection auxiliaries |
| 07/29/2004 | DE10301255A1 Organische Verbindungen mit biologischer Wirkung als Thrombinhemmer und ihre Verwendung Organic compounds having biological activity as thrombin inhibitors and their use |
| 07/29/2004 | CA2513466A1 Organic compounds with biological action as thrombin inhibitors and use thereof |
| 07/29/2004 | CA2513300A1 Obesity-related genes |
| 07/29/2004 | CA2513249A1 Method for in vivo regulation of cardiac muscle contractility |
| 07/29/2004 | CA2513218A1 Peptides and uses thereof for preventing and treating alzheimer's disease(ad) |